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Hepatocyte growth factor activator inhibitor-1 (HAI-1) is a membrane-associated Kunitz-type serine protease inhibitor that regulates cell
surface and extracellular serine proteases involved in tissue remodeling and tumorigenesis, such as HGFA, matriptase, prostasin and hepsin. We
generated HAI-1-deficient mice, which died in utero due to placental defects. The HAI-1−/− placental labyrinth exhibited a complete failure of
vascularization and a compact morphology of the trophoblast layer. Immunofluorescent staining of collagen IV and laminin and electron
microscopy analysis revealed that this aberrant labyrinth architecture was associated with disrupted basement membranes located at the interface
of chorionic trophoblasts and allantoic mesoderm. Unlike the placental labyrinth, basement membranes and vasculogenesis were normal in
embryo and yolk sac. Therefore, basement membrane defects appear to be the underlying cause for the greatly impaired vascularization and
trophoblast branching in HAI-1−/− placentas. In wild-type placentas, the expression of matriptase and prostasin co-localized with their
physiological inhibitor HAI-1 to the labyrinthine trophoblast cells in proximity to basement membranes. In HAI-1−/− placentas, both the
localization and expression of the two proteases remained unchanged, implying uncontrolled proteolytic activities of the two enzymes. Our study
demonstrates the important role of HAI-1 in maintaining the integrity of basement membrane most likely by regulating extracellular proteolytic
activities during placental development.
© 2006 Elsevier Inc. All rights reserved.Keywords: HAI-1; Matriptase; Prostasin; Basement membrane; Placental development; Serine protease; OmniBankIntroduction
HAI-1 is a Kunitz-type serine protease inhibitor expressed in
various epithelial tissues, such as lung, prostate, small intestine,
salivary gland and placenta (Kirchhofer et al., 2003; Shimomura
et al., 1997). HAI-1 is composed of an extracellular domain
containing an N-terminal Kunitz domain (KD1), a low-density☆ During the manuscript revisions, Szabo et al. (Oncogene, advance online
publication 9/18/2006; doi:10.1038/sj.onc.1209966) demonstrated that the
placental labyrinth defects in HAI-1−/− mice are caused by excessive matriptase
activity due to the absence of its physiologic inhibitor HAI-1, consistent with the
results presented herein.
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doi:10.1016/j.ydbio.2006.11.005lipoprotein receptor (LDLR)-like domain and a C-terminal
Kunitz domain (KD2) followed by a transmembrane and a short
cytoplasmic domain. In human, there are two major naturally
occurring splice variants, HAI-1 and HAI-1B, which differ by
the absence or presence of 16 amino acids between KD1 and the
LDLR-like domain (Kirchhofer et al., 2003). In contrast, there is
only one HAI-1 form known in mice (Itoh et al., 2000 and
GenBank search). Enzyme inhibition by HAI-1/1B is mainly
mediated by KD1, whereas KD2 has little or no inhibitory
activity (Denda et al., 2002; Kirchhofer et al., 2003). The
enzyme specificity of HAI-1/1B is quite remarkable as it only
inhibits hepatocyte growth factor activator (HGFA), matriptase,
hepsin, trypsin and prostasin, a recently identified glycosyl-
phophatidylinositol (GPI)-anchored epithelial serine protease
(Fan et al., 2005; Herter et al., 2005; Kirchhofer et al., 2005; Lin
et al., 1999; Miyazawa et al., 1993). Interestingly, the enzyme
specificity as well as binding affinity is completely determined
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HAI-1/1B (Kirchhofer et al., 2003; Shia et al., 2005).
HAI-1/1B is cell membrane associated and is also released as
a soluble form, making it an ideal regulator of cell surface and
extracellular serine proteases. The HAI-1/1B target enzymes,
HGFA, matriptase, prostasin and hepsin, are implicated in tissue
regeneration and remodeling (Itoh et al., 2000, 2004), cell
differentiation, and tumorigenesis (Chen and Chai, 2002;
Kataoka et al., 2000a; Klezovitch et al., 2004; List et al.,
2005; Takeuchi et al., 1999). These processes are likely
mediated by proteolytic processing of substrates resulting in
the generation of bioactive molecules in the peri-cellular
environment. For example, HGFA, matriptase and hepsin
convert single-chain hepatocyte growth factor into its biologi-
cally active two-chain form (Herter et al., 2005; Kirchhofer et
al., 2005; Lee et al., 2000; Miyazawa et al., 1993), which
induces cell proliferation and migration through Met signal
transduction (Birchmeier et al., 2003). In addition, matriptase
activates pro-urokinase, protease-activated receptor-2 (PAR-2)
and processes pro-fillagrin (Lee et al., 2000; List et al., 2003;
Takeuchi et al., 2000). The GPI-anchored prostasin was shown
to activate epithelial sodium channels (ENaC) (Adachi et al.,
2001; Tong et al., 2004) and to process pro-fillagrin during
keratinocyte differentiation (Leyvraz et al., 2005). Deficiency of
either prostasin or matriptase in the epidermis results in the
same skin aberrations (Leyvraz et al., 2005; List et al., 2002),
suggesting that these two proteases participate in similar
physiological processes. The presence of HAI-1 in the
epidermal skin layer indicates that proteases and their inhibitor
may act in concert during epidermal differentiation. The
importance of highly regulated HAI-1/protease systems is
exemplified by the spontaneous formation of neoplasias in
matriptase-overexpressing skin (List et al., 2005). Tumor
formation was completely prevented by skin-directed over-
expression of HAI-1. It is remarkable that tumor induction and
rescue by HAI-1 were the consequences of modest changes in
the relative expression level of matriptase and HAI-1. There-
fore, imbalances of HAI-1 to its target proteases may cause
significant alterations of normal processes.
Changes in expression levels of HAI-1 as compared to its
target enzymes were observed in many tumors. For instance, in
prostate cancer, both hepsin and matriptase expression were
upregulated (Magee et al., 2001; Riddick et al., 2005), whereas
expression of HAI-1 remained unchanged (Riddick et al.,
2005). Similar enzyme/HAI-1 imbalances were also found in
colorectal and ovarian cancer (Kataoka et al., 2000a; Oberst et
al., 2002).
While mainly serving as a protease inhibitor, HAI-1 may
also regulate the expression, activation and local concentra-
tion of proteases (Benaud et al., 2001; Kataoka et al.,
2000b; Oberst et al., 2005). These activities of HAI-1 may
be related to the proposed pro-invasive and tumorigenic
function of HAI-1 (Miyata et al., 2005; Nagaike et al.,
2004). Moreover, overexpression of membrane-associated
HAI-1, but not the secreted-form of HAI-1, significantly
enhanced the tumorigenicity of glioblastoma cell lines in
vivo (Miyata et al., 2005). These diverse functions of HAI-1 may reflect its complex roles in multiple biochemical
events through interacting with proteases and yet unidenti-
fied molecules.
The importance of HAI-1 in development was examined
by Tanaka et al., who found that HAI-1 deficiency was
embryonic lethal due to severely impaired formation of the
placental labyrinth (Tanaka et al., 2005). However, the
underlying mechanism remained elusive. In this study, we
have independently generated and analyzed mice lacking a
functional HAI-1 gene by use of the gene-trapping technol-
ogy. We show that the failure of placental development in
HAI-1−/− mice is associated with the disruption of basement
membranes. Further investigation suggests that matriptase
and/or prostasin expressed on the surface of trophoblast cells
contribute to the disruption of basement membrane detri-
mental to trophoblast branching morphogenesis and vascular-
ization of the labyrinth.
Materials and methods
Generation of HAI-1 deletion mice
The HAI-1+/− mice were generated by Lexicon Genetics Incorporated (The
Woodlands, TX) using random retroviral gene-trapping in embryonic stem cells
as previously described (Zambrowicz et al., 2003). Tail DNAwas genotyped by
PCR using a pool of three primers (as illustrated in Fig. 1A). The sequences of
these primers are: a, 5′-GGCAGTGGCCTGTGAG-3′; b, 5′-AAATGGCGT-
TACTTAAGCTAGCTTGC-3′; c, 5′-CCCTAAAGGGATGTTGTCCTGGG-3′.
HAI-1−/− embryos were generated by heterozygous intercross, and their
genotypes were determined by PCR amplification.
Reverse transcription-PCR
To confirm the disruption of full-length transcript in the homozygous
embryo, total RNA was isolated from E9.5 embryos using TRIzol Reagent
(Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. 1 μg
total RNA was processed by use of oligo(dT)24 and SuperScript reverse
transcriptase (Invitrogen). The cDNAs were subjected to PCR using the primer
set of HAI-1 (as illustrated in Fig. 1A) and ribosomal protein L 19 (RPL19). The
sequences of the primer set for HAI-1 were: 5′-CGAGCAGAACTTCGTGTG-
CAAG-3′ and 5′-CATCACTGTCACCTTGCAGTAGG-3′. For the analysis of
RNA levels of HAI-1 target enzymes, total mRNA was isolated from E9.5
placentas followed by RT-PCR as described above. Control murine mRNAs
(liver for HGFA and hepsin, colon for matriptase, placenta for prostasin) were
purchased from BD Bioscience.
Whole-mount immunohistochemistry
The anti-cHAI-1 polyclonal antibody was generated by injecting rabbits
with a synthesized peptide spanning the cytoplasmic domain of human HAI-1/
1B (Lys489-Leu529 in HAI-1B) using standard techniques. The rabbit sera with
highest titer were pooled and the antibody was affinity-purified. The anti-cHAI-
1 antibody reacts with both human and murine HAI-1.
E9.5 embryos were fixed in methanol containing 20% DMSO for 3 h
at room temperature and bleached in 10% H2O2. They were then subjected
to immunoperoxidase staining using the anti-cHAI-1 polyclonal antibody at
5 μg/ml.
Histological analysis
Embryos or placentas were fixed in 4% paraformaldehyde (PFA) overnight
at 4°C, followed by dehydration through an ethanol series. Tissues were cleared
Fig. 1. Disruption of HAI-1 gene. (A) Schematic representation of retroviral integration and primer design for PCR genotyping (arrows: a, b, c) and RT-PCR (arrows: I
and II). The probe used for in situ hybridization (bar: pb) was located at 3′-UTR. LTR, viral long terminal repeat. (B) PCR and RT-PCR. PCR products from genomic
DNA of E9.5 embryos were amplified by primers a and c for the wild-type allele (wt), and primers b and c for the mutated allele (mt). The disruption of HAI-1
transcript was determined by RT-PCR using primers I and II. RPL19 was used as control. (C) Whole-mount immunohistochemical staining of E9.5 embryos with anti-
cHAI-1 antibody. Brown staining was observed in the branchial arches (arrow) and otic vesicle (arrow head) of wild-type embryo (+/+), but not in the homozygous
HAI-1−/− embryo (−/−).
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and stained with hematoxylin and eosin.
Whole-mount in situ hybridization
Whole-mount in situ hybridizations were carried out as described previously
(Shimamura et al., 1994) with slight modifications. Digoxigenin-labeled
antisense probes were made using an RNA transcription kit (Roche
Diagnostics). Probe specific for HAI-1 was prepared from a murine HAI-1
partial cDNA clone (GenBank accession no. AA739106). cDNA fragments
containing 350–500 bp 3′ noncoding regions of Gcm1 (cloned from placental
total RNA), matriptase (colon), prostasin (placenta), hepsin and HGFA (liver)
were inserted into pCR4-TOPO vector (Invitrogen) and were used as templates
for probe synthesis. Other probes used were: the endothelial cell marker Flk1
(Millauer et al., 1993) and the trophoblast cell marker Dlx3 (Morasso et al.,
1999). Following whole-mount in situ hybridization analysis, samples were re-
fixed in 4% paraformaldehyde in PBS, dehydrated through an ethanol series and
xylenes, and embedded in paraffin. 10 μm sections were prepared and
counterstained with 0.2% nuclear fast red (Sigma).
Immunofluorescent staining
Tissues were embedded in OCT compound (Tissue-Tek) and frozen
immediately. 10 μm cryosections were fixed in acetone and subjected to
immunofluorescent staining with anti-mouse collagen IV (1:80 dilution) and
anti-mouse laminin (1:160 dilution) polyclonal antibodies (Chemicon). The
sections were then incubated with Cy3-conjugated secondary antibody
(Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) and
counterstained with DAPI (Invitrogen).
Transmission electron microscopy
The placentas were fixed in a modified Karnovsky's fixative (2%
paraformaldehyde, 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer,
pH 7.2), washed in the same buffer, and post-fixed in 1% aqueous osmium
textroxide for 1 h. The samples were then dehydrated through a series of
ethanol, followed by propylene oxide and embedded in Eponate 12 (Ted
Pella, Redding, CA). Thin sections were cut on a Reichert Ultracut E,
stained with uranyl acetate and lead citrate and examined in a Philips
CM12 transmission electron microscope. Images were captured with a
GATAN Retractable Multiscan digital camera.Results
Characterization of HAI-1−/− mice generated by gene trapping
HAI-1-deficient mice were generated using random
retroviral gene trapping in embryonic stem cells (Zambro-
wicz et al., 2003). The retroviral vector was inserted into
the intron of the HAI-1 gene between exons 2 and 3 (Fig.
1A), leading to disruption of the full-length transcripts. PCR
analysis of genomic DNA isolated from the targeted mouse
embryos confirmed that the HAI-1 gene had been disrupted
(Fig. 1B). Standard RT-PCR using a pair of primers located
at exons 2 and 3 showed that no transcript was detected in
the homozygous embryo (Fig. 1B). To further confirm the
absence of HAI-1 protein in the knockout mice, we
performed whole-mount immunohistochemical analysis
with an antibody raised against the cytoplasmic domain of
HAI-1. In E9.5 wild-type embryos, HAI-1 was expressed in
the branchial arches and otic vesicles, while no signal was
detected in the homozygous embryos (Fig. 1C).
Consistent with the results by Tanaka et al. (2005), mice
lacking HAI-1 died in utero at E10.5 to E11.5 (see Supplemental
data, Table S1) due to defects of the placental labyrinth
architecture.
HAI-1−/− trophoblasts express Gcm1 despite attenuated
branching morphogenesis
The defects in the labyrinth were further studied by in situ
hybridization using the trophoblast marker Dlx3, which
showed that the trophoblast layer of the HAI-1−/− placenta
was considerably smaller, compared to the wild-type placenta
(Fig. 2A). The compact morphology indicated that tropho-
blasts failed to branch or migrate properly in the absence of
HAI-1.
Fig. 2. Whole-mount in situ hybridization of wild-type (+/+) and HAI-1−/− (−/−) placentas. These placentas were then sagittally sectioned and counterstained with
nuclear fast red for histological analysis. (A) Dlx3 (trophoblast cell marker) expression in E10.5 placentas. (B) Gcm1 expression in E9.5 placentas. Note that the
evagination points at the chorioallantoic plate (black arrows) and the elongated trophoblast cells at branching sites (yellow arrows) stained strongly for Gcm1 in both
wild-type (+/+) and HAI-1−/− (−/−) placentas. lb, Labyrinthine layer; sp, spongiotrophoblast layer; al, allantois. Scale bars, 100 μm.
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branching morphogenesis. Its punctuated expression pattern
defines the chorioallantoic branching points within the
chorionic plate (Anson-Cartwright et al., 2000). Tanaka et al.
reported that Gcm1 expression quantified by RT-PCR was
strongly reduced in HAI-1−/− placentas (Tanaka et al., 2005).
This result implied that the reduced Gcm1 expression was
involved in the failure of trophoblast branching in HAI-1−/−
placenta. We performed in situ hybridization experiments with
placentas of E9.5 to visualize the distribution of Gcm1 in
labyrinth. In wild-type placentas, Gcm1 was broadly expressed
throughout the labyrinth, with intensified signals in a subset of
trophoblast cells defining the branching sites (Fig. 2B). In the
homozygous mutant placentas, a similar expression pattern of
Gcm1 was observed (Fig. 2B), indicating that the failure of
trophoblast branching was not due to the lack of Gcm1.
However, in HAI-1−/− placentas most of these initial branching
sites failed to expand and to develop a villous morphology.
Hence, the number and depth of the branches in mutants were
less than those in the wild-type placentas, explaining the
reduced total mRNA levels of Gcm1 reported by Tanaka et al.
(2005).The vascularization defect in HAI-1−/− mice is restricted to the
placental labyrinth
In situ hybridization of Flk1, a specific marker for fetal
endothelial cells (Millauer et al., 1993), showed that the
vascular defects were restricted to the placental labyrinth
(Figs. 3A, B). In contrast, the vascularization of the HAI-1−/−
embryo and yolk sac were normal (Figs. 3C, D). Moreover,
the confinement of vascularization defects to the labyrinth
layer was clearly visible at the allantois-labyrinth juncture,
where the fetal endothelial cells in the allantois failed to
extend into the labyrinthine region in the HAI-1−/− placenta
(Figs. 3A, a, B, b). Therefore, the impaired vascularization in
the HAI-1−/− placenta was not a result of defective embryonic
endothelial cells.
Basement membrane defects in the HAI-1−/− placental
labyrinth
The lack of fetal blood vessels and reduced size of the
trophoblast layer in the HAI-1−/− placenta are akin to the
placental defects in collagen IV-deficient mice, which displayed
Fig. 3. Whole-mount in situ hybridization with antisense probe for Flk1. These samples were then sectioned and counterstained with nuclear fast red (a, b, D). (A and
a) E10.5 wild-type placenta. (B and b) E10.5HAI-1−/− placenta. (Inset of b) Hematoxylin and eosin staining of E10.5HAI-1−/− placental labyrinth. Note the fetal blood
vessels (arrows) in the allantois looked normal. (C) E9.5 HAI-1−/− embryo. (D) E10.5 HAI-1−/− yolk sac. lb, labyrinth layer; sp, spongiotrophoblast layer; al, allantois;
ys, yolk sac. Scale bars, 100 μm.
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malformation (Poschl et al., 2004). Therefore, the integrity of
basement membranes in HAI-1−/− placentas was examined by
immunofluorescent staining of collagen IV and laminin, two
major components of basement membranes. In the wild-type
E10.5 placental labyrinth, collagen IV and laminin staining was
localized to the basement membranes separating chorionic
trophoblasts from allantoic mesoderm, and to those surrounding
the fetal blood vessel branches (Figs. 4A, C). In contrast,
collagen IV and laminin staining in HAI-1−/− placentas was
patchy and discontinuous (Figs. 4B, D), indicating that the
basement membranes were disrupted. However, collagen IVand
laminin in the Reichert's membrane and yolk sac appeared
normal (Figs. 4E–H), suggesting that the defects in the
basement membranes were restricted to the labyrinth. In
support of this conclusion, the collagen IV and laminin
networks in other HAI-1-expressing tissues appeared normal,
including branchial arches (Figs. 4I–L) and limb buds (data not
shown).
Transmission electron microscopy analysis of basement
membranes in E10.5 placentas further supported the changes we
observed by immunofluorescent staining. Wild-type placenta
had continuous basement membranes at the interface of
trophoblasts and allantoic mesoderm, whereas the basement
membranes of HAI-1−/− placental labyrinth displayed a
disorganized structure (Fig. 5). Amorphously deposited
matrices on the trophoblast surface, basement membranes of
less electron density and fragmented appearance were seen in
the HAI-1−/− labyrinth.
Expression of serine proteases in placenta
In order to investigate possible mechanisms leading to
basement membrane disruption in the HAI-1−/− labyrinth, theexpression of HAI-1 and its target proteases were analyzed.
HAI-1 was expressed in the labyrinth layer of placenta (Fig.
6A), but was not detected in the spongiotrophoblast or giant
cell layers. The expression of HAI-1 mRNA in the labyrinth
was relatively widespread and was associated with two
morphologically distinct cell populations, the elongated
syncytiotrophoblasts and the cuboidal mononuclear tropho-
blasts (Fig. 6A).
Neither hepsin nor HGFA was detected in the placentas
of wild-type or HAI-1−/− mice using in situ hybridization
(Fig. 6C). Lack of hepsin and HGFA expression was
confirmed by RT-PCR experiments (Fig. 6B). However,
strong expression of both matriptase and prostasin was
observed in the labyrinth layer (Figs. 6C, D). In wild-type
placenta, matriptase was mainly expressed in the cuboidal
trophoblasts localized to the basal layer of the chorioallan-
toic plate, and weakly expressed in the elongated syncytio-
trophoblasts (Fig. 6D, inset). Matriptase expression was
identical in HAI-1−/− placentas (Fig. 6D). Prostasin was broad-
ly expressed throughout the normal labyrinth including the
elongated syncytiotrophoblast population and the cuboidal
trophoblasts (Fig. 6D, inset). Interestingly, within the
cuboidal trophoblast cell population, prostasin expression
was not detectable in the basal layer. Prostasin expression
was also observed in the spongiotrophoblast cells. A similar
expression pattern was found in HAI-1−/− placentas (Fig.
6D). Expression of HAI-1, prostasin and matriptase in wild-
type placentas continued through E10.5 with an identical
expression pattern as described for the E9.5 placentas (data
not shown).
Furthermore, in wild-type embryos and yolk sac, HAI-1 was
co-expressed with either matriptase or prostasin, but never with
both proteases in the same location. In E9.5 wild-type embryos
matriptase and HAI-1 were co-expressed in branchial arches,
Fig. 4. Immunofluorescent staining of E10.5 wild-type (+/+) and HAI-1−/− (−/−) placentas and embryos with anti-mouse collagen IV (Col IV) and anti-mouse laminin
(Lam) antibodies. (A–D) Placentas. The basement membranes separating chorionic trophoblast from allantoic mesoderm are indicated by the white dotted lines, and
the punctuated staining inHAI-1−/− placentas are highlighted by white arrows in panels B and D. The basement membranes surrounding the fetal blood vessel branches
in the placenta are indicated by green arrows. lb, Labyrinth; al, allantois. (E–H) Yolk sac (ys) and Reichert's membrane (RM). (I–L) Branchial arches. Arrows indicate
the position of basement membrane.
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tissues (Fig. 6E). On the other hand, prostasin and HAI-1 were
co-expressed in the yolk sac, where matriptase was absent (Fig.
6E). Thus, the placental labyrinth is the only location whereFig. 5. Transmission electron microscopy of E10.5 placentas. Basement membranes in
1−/− placentas, basement membranes underlying trophoblast cells displayed areas of l
trophoblast; Mi, mitochondria. Scale bars, 0.5 μm.both matriptase and prostasin are expressed along with HAI-1.
The expression of matriptase (branchial arches, otic vesicles and
limb buds) and prostasin (yolk sac) remained unchanged in
HAI-1−/− mice, whose E9.5 yolk sacs and embryos had normalwild-type (+/+) andHAI-1−/− (−/−) placentas are indicated by brackets. In HAI-
ower electron-density, fragmentations (*), and amorphous deposits (arrows). Tb,
Fig. 6. Expression of HAI-1 and its target enzymes in E9.5 placentas and embryos detected by whole-mount in situ hybridization (A, C–E) and RT-PCR (B). (A) HAI-1
is expressed in the cuboidal trophoblast cells (blue arrow) and elongated syncytiotrophoblasts (black arrow) in wild-type placental labyrinth. (B) RT-PCR analysis
using total mRNAs extracted from E9.5 placentas. ctr, Control mRNA. (C) Expression of matriptase, prostasin, hepsin and HGFA in wild-type placentas. Strong blue
staining was seen for matriptase and prostasin. (D) Matriptase and prostasin expression in wild-type (+/+) and HAI-1−/− (−/−) placentas. Insets show the higher
magnification view of the chorionic trophoblast layer. Matriptase is located in the basal layer cuboidal trophoblasts (yellow arrows) while prostasin is expressed in
other cuboidal trophoblast cells (red arrows). Both are expressed in the elongated syncytiotrophoblasts (black arrows). (E) Expression of HAI-1, matriptase and
prostasin in wild-type yolk sacs (ys) and embryos. HAI-1 and matriptase are expressed in the branchial arches (black arrows), otic vesicle (blue arrows) and limb bud
(red arrows). HAI-1 and prostasin are expressed in yolk sac. fv, Fetal blood vessel; lb, labyrinth layer; al, allantois; sp, spongiotrophoblast layer. Scale bars, 100 μm.
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shown).
Discussion
The herein described HAI-1-deficient mice died in utero at
E10.5–11.5 due to placental failure, which is in full
agreement with a recent study by Tanaka et al. (2005).
Thus, the results obtained by two independent experimental
approaches, i.e., by use of gene-trapping technology (our
study) and homologous recombination (Tanaka et al., 2005)
firmly establish that HAI-1 is essential for the proper
formation of the placental labyrinth.
The placental defects in HAI-1−/− embryos are localized to
the labyrinth, a site of strong HAI-1 expression in wild-type
placentas, and the defects included a complete failure of
vascularization and a small compact trophoblast layer. By
immunohistochemical staining experiments, we show that thebasement membranes in the HAI-1−/− labyrinth had lost their
structural integrity, which was further confirmed by electron
microscopy analysis. However, the basement membranes in the
embryo and yolk sac remained normal. Thus, the site of the
disrupted basement membranes, i.e., the placental labyrinth,
fully correlated with the vascular defects, suggesting a cause–
effect relationship between these two aberrant processes.
Basement membranes are known to provide distinct spatial
and molecular information that promotes blood vessel forma-
tion by endothelial cells (Hallmann et al., 2005). Among the
major components of basement membranes, type IV collagen
provides a scaffold for the binding of other proteins (Timpl and
Brown, 1996). Type IV collagen gene deletion caused structural
deficiencies in the basement membranes resulting in embryonic
lethality at E10.5–11.5 of gestation (Poschl et al., 2004), which
is identical to HAI-1−/− mice. The lack of fetal blood vessels in
the labyrinth layer of the collagen IV-deficient placenta closely
resembles the labyrinthine defects in HAI-1−/− placenta.
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markedly reduced vessel branching in the labyrinth (Miner et
al., 1998). Together, these findings strongly suggest that the
disruption of basement membranes is the major cause of the
vascularization failure of HAI-1−/− placenta. Moreover, the
mice deficient of collagen IV also displayed a smaller
trophoblast layer (Poschl et al., 2004) as seen in the HAI-1−/−
labyrinth, implying that the collagen IV network is involved in
trophoblast branching morphogenesis. Laminin may also
participate in this process because it has been shown to promote
the attachment, spreading and migration of trophoblasts
(Qureshi et al., 2000; Romagnano and Babiarz, 1993). The
observed defects in the HAI-1−/− labyrinth, lack of vasculariza-
tion and compact trophoblast layer, may not be independent
events, because labyrinth vascularization greatly depends on the
branching morphogenesis of trophoblasts (Rossant and Cross,
2001). Hence, the disruption of collagen IV and laminin
network in the HAI-1−/− placenta very likely attenuated the fetal
blood vasculature formation by affecting the endothelial cells to
form blood vessels and by reducing the motility of trophoblast
cells. Such an interpretation would also explain why trophoblast
branching morphogenesis was attenuated despite the presence
of Gcm1-positive chorioallantoic branching points.
In trophoblasts, the spatial and temporal expression of HAI-1
correlated with the two cell surface proteases matriptase and
prostasin, suggesting that in normal placenta the activities of
matriptase and prostasin are likely regulated by their physio-
logic inhibitor HAI-1. However, the proteases' roles during
placental development remain unknown. Our results suggest
that basement membrane disruption in the labyrinth and the
ensuing placental defects may originate from increased
activities of matriptase and prostasin in HAI-1−/− trophoblasts,
where their physiologic inhibitor HAI-1 was absent. It is
currently unclear how increased proteolytic activities are linked
to basement membrane disruption in the labyrinth. This
question is further complicated by the finding that neither
matriptase nor prostasin by itself caused any basement
membrane defects or abnormalities in extra-placental tissues
in HAI-1−/− mice. It may be that the labyrinth is particularly
vulnerable to increased activity of either protease, or more
likely, that there exists a functional synergism between the two
proteases in the labyrinth. The latter possibility would explain
why the defects were limited to the placental labyrinth, which is
the only site where matriptase and prostasin are co-expressed.
The activation of degradative pathways by matriptase-mediated
pro-uPA processing (Lee et al., 2000; Takeuchi et al., 2000)
might be part of the mechanism that resulted in basement
membrane disruption.
HAI-1 has also been implicated in regulating proteases, such
as matriptase, HGFA and hepsin, during invasive tumor growth
and metastasis. The molecular pathways controlling trophoblast
migration and morphogenesis are akin to tumor invasion and,
therefore, it seems plausible that high protease and low HAI-1
levels found in many tumors may facilitate basement membrane
degradation and cancer cell invasion. In support of this view,
overexpression of hepsin caused basement membrane disorga-
nization similar to that observed in the placental labyrinth andled to prostate cancer progression and metastasis (Klezovitch et
al., 2004). Future studies on tissue-specific HAI-1 deletions
should provide further insight into the role of HAI-1 in
physiology and tumorigenesis.
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